About this trial
Burnout is highly prevalent among oncology clinicians, including residents in training. This prospective, mixed-methods, quasi-experimental study will evaluate how burnout changes over 12 months during the first year of medical oncology residency and explore which work-related, professional identity, and program support factors influence this variation.
Residents will participate in a structured self-care and burnout prevention program with multiple modules (e.g., yoga, mindfulness, art therapy, music therapy, Balint groups, workshops, mentorship). Quantitative burnout outcomes will be measured using the Maslach Burnout Inventory (MBI-HSS), and qualitative insights will be collected through individual semi-structured interviews. The study will also describe sociodemographic characteristics, baseline burnout prevalence, participation/adherence, satisfaction, and implementation barriers/facilitators.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
First-year medical oncology residents at FALP; continued residency enrollment; minimum attendance requirement per protocol (≥75%).
Disqualifiers
Maternity leave during the study period.
Interruption/withdrawal from the residency program.
Trial design
Single group
Treatments tested in this trial
Self-Care and Burnout Prevention Program
Behavioral(EN): Multi-component wellness program delivered over 12 months (e.g., yoga, mindfulness, art therapy, music therapy, Balint groups, workshops, mentorship). Attendance/adherence is tracked; participant feedback is collected to evaluate satisfaction and implementation barriers/facilitators.
Treatment groups
Trial outcomes
Primary outcomes
Burnout (MBI-HSS domains). Maslach Buront Inventory
Maslach Burnout Inventory-Human Services Survey (MBI-HSS) domains: Emotional Exhaustion, Depersonalization, and Personal Accomplishment.
Secondary outcomes
Baseline burnout prevalence (baseline).
Maslach Burnout Inventory-Human Services Survey (MBI-HSS) domains: Emotional Exhaustion, Depersonalization, and Personal Accomplishment. at baseline
Other outcomes
Attendance rate to scheduled program sessions (%)
Attendance will be calculated as: (number of scheduled sessions attended ÷ number of scheduled sessions offered) × 100 over the 12-month program. Attendance will be documented using program session attendance logs (and stored in REDCap). This aligns with the objective to characterize adherence/participation by quantifying attendance.Unit of Measure: Percent (%)
Overall program satisfaction score assessed by post-program satisfaction survey (Likert 1-5)
Participants will complete a post-program quantitative satisfaction survey at program completion. Overall satisfaction will be rated on a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied). Results will be summarized as mean (SD) and/or median (IQR).Unit of Measure: Score (1-5)
Identification of barriers and facilitators to implementation
To identify barriers and facilitators to program implementation and participation, explored through qualitative analysis of semi-structured interviews and participant feedback, including organizational, workload-related, personal, and contextual factors influencing engagement and feasibility.
Participants completing ≥75% of scheduled program sessions (%)
A participant will be considered adherent if they complete at least 75% of the scheduled program sessions during the 12-month period. The outcome will be reported as the proportion of participants meeting this threshold. This is consistent with the protocol criterion of ≥75% session completion.Unit of Measure: Percent (%)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: